Opthea in crisis as eye treatment fails in spectacular default
MELBOURNE: Biotechnology firm Opthea has warned investors its solvency is in question after ... read more
Healthscope flatlining and clock is ticking on its demise
MELBOURNE: Investors are feeling the pain after one of Healthscope’s biggest landlords, a ... read more
Pathology firms watch budget as uplift to balance sheets intimated
CANBERRA: Among companies watching the budget tonight are likely to be pathology providers. ... read more
